Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.
about
The Genetic Basis of Cognitive Impairment and Dementia in Parkinson's DiseaseBiomarkers for dementia and mild cognitive impairment in Parkinson's disease.Functional brain networks and abnormal connectivity in the movement disorders.Genetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD studyGenetic influences on cognitive decline in Parkinson's disease.The Val158Met COMT polymorphism is a modifier of the age at onset in Parkinson's disease with a sexual dimorphism.Putative cortical dopamine levels affect cortical recruitment during planning.What can biomarkers tell us about cognition in Parkinson's disease?Pharmacogenetics of drug response in Parkinson's disease.Does response inhibition have pre- and postdiagnostic utility in Parkinson's disease?Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease.Genetic Variation and Neuroplasticity: Role in Rehabilitation After Stroke.Genetic risk factors for cognitive decline in Parkinson's disease: a review of the literature.How close are we to individualized medicine for Parkinson's disease?Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson's disease.Methylphenidate : a treatment for Parkinson's disease?Association of Catechol-O-methyltransferase val/met polymorphism with cognitive function in Gilles de la Tourette syndrome patients.
P2860
Q26744716-914F186A-A430-4854-8128-BF89091471F1Q31097119-EEF28025-1FE0-4782-822E-034112643532Q34114125-BAE85335-845D-455E-BA8E-BC5ACB640FD8Q34174901-77BFA77B-9972-4D5C-9369-EA987E44897AQ35881786-87859483-32FF-426E-BEF3-695665A3E58EQ36822049-A49534A9-0103-4120-A191-A7C8F69883A3Q37254819-2F0339FD-7239-4D15-BC6C-B8B7DEFFA645Q38206497-5C20E3B3-23BF-4AAF-B293-8E1504A587D4Q38250117-3C2B0C2E-EA83-4D57-B700-CB6B7D19DF4AQ38313013-5FA8B379-1D50-4864-8F1E-A73671EF4CF3Q38376569-9144B094-3EF5-48D3-BAA2-1300FCE1CCB2Q38669324-4C14D093-7CDE-4BA3-B513-942F2A74100EQ38755102-E60B2DDD-5A58-4FE5-B26C-948A9D0BE4F2Q38814888-D44DC780-C5C1-446A-BB58-BCD7CDB90AFAQ41168222-B7923CE6-329B-4419-A5EA-AB50B5723D36Q48290666-8498F3AC-9B90-406C-8004-9EAD8D705C96Q48818611-550BB9BC-EEFC-4C35-A80E-8513E931E9D5
P2860
Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.
@en
Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.
@nl
type
label
Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.
@en
Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.
@nl
prefLabel
Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.
@en
Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease.
@nl
P2093
P2860
P356
P1433
P1476
Catechol-O-methyltransferase val158met and cognitive function in Parkinson's disease
@en
P2093
Ben Schmand
Dino Muslimović
Jeroen Hoogland
Rob M A de Bie
P2860
P304
P356
10.1002/MDS.23319
P407
P577
2010-11-01T00:00:00Z